SPRO - スマ―トプロス (Spero Therapeutics Inc.)

SPROのニュース

   Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to Decline  2020/03/05 17:30:40 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Spero Therapeutics : An amendment to the SC 13G filing | MarketScreener  2020/01/31 22:55:08 MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the… | January 31, 2020
   Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates  2019/08/09 00:30:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -29.82% and -68.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release  2019/08/01 14:33:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates  2019/05/10 00:15:05 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 62.34% and 517.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
   Earnings Preview: Spero Therapeutics, Inc. (SPRO) Q4 Earnings Expected to Decline  2020/03/05 17:30:40 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Spero Therapeutics : An amendment to the SC 13G filing | MarketScreener  2020/01/31 22:55:08 MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the… | January 31, 2020
   Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates  2019/08/09 00:30:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -29.82% and -68.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release  2019/08/01 14:33:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates  2019/05/10 00:15:05 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 62.34% and 517.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
   Spero Therapeutics, Inc. (SPRO) Reports Q2 Loss, Misses Revenue Estimates  2019/08/09 00:30:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of -29.82% and -68.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
   Spero Therapeutics, Inc. (SPRO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release  2019/08/01 14:33:06 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Spero Therapeutics, Inc. (SPRO) Reports Q1 Loss, Tops Revenue Estimates  2019/05/10 00:15:05 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 62.34% and 517.44%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
   Spero Therapeutics reports Q1 results  2019/05/09 21:05:23 Seeking Alpha
   Analysts Estimate Spero Therapeutics, Inc. (SPRO) to Report a Decline in Earnings: What to Look Out for  2019/05/02 14:32:38 Zacks Investment Research
Spero Therapeutics, Inc. (SPRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

calendar